DeNovix Inc. has officially launched its latest product, CellGlow, designed to enhance the process of assessing cell viability. This new assay is ready-to-use and specifically aimed at automating cell counting procedures, making it a significant advancement in the field.
CellGlow allows researchers to quickly and accurately determine cell viability, which is crucial for various applications in biomedical research and drug development. The simplicity and efficiency of the assay promise to save valuable time and resources in laboratory settings.
With the growing importance of cell viability data in research, the introduction of this product addresses a critical need for reliable and easy-to-use solutions. The technology behind CellGlow represents a leap forward in ensuring that researchers have access to the best tools for their work.
This innovation is part of DeNovix’s commitment to providing high-quality, user-friendly research products that enhance laboratory efficiency. For more information, you can visit the original announcement on News-Medical.
Source: News-Medical